Xian Jin

Title: Xian Jin: Innovator in Bone Disease Treatment

Introduction

Xian Jin is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of bone diseases. His innovative work has led to the development of a unique composition that addresses critical health issues related to bone density and strength.

Latest Patents

Xian Jin holds a patent for a pharmaceutical composition comprising 4-hexylresorcinol as an active ingredient for the prevention or treatment of bone disease. This invention relates to a formulation that utilizes 4-hexylresorcinol (4-HR) to improve bone thickness, density, and strength. The composition has been shown to control bone remodeling by promoting the differentiation of osteoblasts while suppressing the proliferation and differentiation of osteoclasts in osteoporosis-induced animal models. This therapeutic agent can be beneficial for conditions such as bone fractures, osteoarthritis, rheumatoid arthritis, and osteoporosis.

Career Highlights

Throughout his career, Xian Jin has been associated with prominent institutions, including the Kyungpook National University Industry-Academic Cooperation Foundation and the Gangneung-Wonju National University Industry Academy Cooperation Group. His work in these organizations has facilitated advancements in research and development in the pharmaceutical sector.

Collaborations

Xian Jin has collaborated with esteemed colleagues, including Je-Yong Choi and Xiangguo Che. These partnerships have contributed to the success of his research and the impact of his inventions in the field.

Conclusion

Xian Jin's innovative contributions to the treatment of bone diseases through his patented pharmaceutical composition highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in bone health and therapeutic solutions.